GHRP-6 and CJC-1295 DAC Blend Nasal Spray
GHRP-6 + CJC-1295 DAC Blend Nasal Spray combines GHRP-6, a synthetic growth hormone-releasing hexapeptide, with CJC-1295 DAC, a modified growth hormone-releasing hormone (GHRH) analogue, and is available from Direct SARMs in 15 ml and 30 ml sizes.
TOP SELLER
Batch COA includedStore 2–8°C
Price range: $31.18 through $56.10
Buy more, save more
7.5% offspend $250.00
12.5% offspend $400.00
Spend $250.00 for 7.5% off on qualifying items · Applied automatically at checkout
Researchers who bought GHRP-6 and CJC-1295 DAC Blend Nasal Spray also bought
GHRP-6 and CJC-1295 DAC Blend Nasal Spray
GHRP-6 and CJC-1295 DAC Blend combines two synthetic research peptides associated with distinct neuroendocrine signalling pathways. GHRP-6 is a growth hormone-releasing hexapeptide belonging to the growth hormone secretagogue class, while CJC-1295 DAC is a modified growth hormone-releasing hormone (GHRH) analogue incorporating a Drug Affinity Complex.
Direct SARMs supplies the blend as a pre-mixed aqueous nasal spray format for laboratory research, containing 2.5 mg in the 15 ml size and 5 mg in the 30 ml size. The nasal spray designation describes the physical presentation of the material and does not establish intranasal bioavailability, biological activity, synergy or suitability for administration.
Documentation includes a Certificate of Analysis (COA) and HPLC purity report to provide analytical information about the supplied material and support laboratory traceability.
GHRP-6 and CJC-1295 DAC Blend Nasal Spray is supplied solely for laboratory research and is not intended for human or veterinary use.
Benefits of the nasal spray format
1
The dispensing is pre-measured. Each time the spray mechanism is actuated, it releases a constant volume, which allows for repeatable dispensing when carrying out research procedures.
2
Convenient format. Compact spray bottles are straightforward to store, handle, and transport within an appropriate research environment.
3
Ready to use. Unlike lyophilized peptides, which are provided in vials, nasal spray formulations are in liquid form and do not need to be reconstituted before being handled in the laboratory.
4
Protected storage. The bottle protects the formulation by preventing unnecessary handling and exposure to the environment between research procedures.
5
Simple dispensing. The product can be dispensed easily. With an integrated spraying mechanism, it is not necessary to draw the liquid from a vial, offering a simple way to dispense the formulation during research.
Visit the GHRP-6 Peptide Research Hub ▸
Visit the CJC-1295 DAC Peptide Research Hub ▸
Read the GHRP-6 and CJC-1295 DAC research guide ▸
Read the GHRP-6 and CJC-1295 DAC research guide ▸
GHRP-6 and CJC-1295 DAC is supplied exclusively for laboratory research use. The information on this page is provided for scientific and educational reference and is based on available published research. This product is not intended for human or veterinary use, diagnosis, treatment, or prevention of any disease or medical condition. It is intended solely for qualified laboratory research and must be handled in accordance with applicable laboratory safety requirements.
Buy GHRP-6 and CJC-1295 DAC Blend Nasal Spray Poland from Direct SARMS.
Additional information
| Size(s) | 15ml and 30ml |
| Amount Per Nasal | 15ml = 2.5mg (1.7mg GHRP-6 / 0.8mg CJC-1295 DAC) | 30ml = 5mg (3.4mg GHRP-6 / 1.6mg CJC-1295 DAC) |
| Purity | |
| Molecular Formula | C46H56N12O6 | C152H252N44O42 |
| Molecular Weight | 873.01 g/mol | 3367.9 g/mol |
| Sequence | H-His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 | H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 |
| Physical Form | Pre-mixed aqueous solution |
General information
Applies to all Direct Sarms research compounds unless noted otherwise on the product.
Storage & handling
Store the nasal spray according to the instructions provided on the product label. Keep the bottle securely closed when not in use and protect it from excessive heat and direct light. Follow any product-specific refrigeration requirements stated on the label.
Shipping & discretion
Fully tracked dispatch with worldwide shipping available. Sent in plain, discreet outer packaging with no product description on the label.
FDA disclosure & intended use
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Research use only — not for human or animal consumption. You must be 18+ and a qualified researcher.
Got a question about this GHRP-6 and CJC-1295 DAC compound?
The blend is supplied as a pre-mixed aqueous solution for laboratory research.
Direct SARMs supplies GHRP-6 + CJC-1295 DAC Nasal Spray in 15 ml and 30 ml formats.
The formulation combines GHRP-6, a synthetic growth hormone-releasing hexapeptide, with CJC-1295 DAC, a modified growth hormone-releasing hormone (GHRH) analogue containing a Drug Affinity Complex.
DAC stands for Drug Affinity Complex, a chemical modification incorporated into CJC-1295 that distinguishes it from non-DAC GHRH analogues.
No. The presence of both research compounds in a single formulation does not by itself establish synergy, biological activity, intranasal bioavailability, safety or efficacy.
Certificate of Analysis
| Identity | GHRP-6 and CJC-1295 DAC | CONFORMS |
| Mass (LC-MS) | 873.01 g/mol | 3367.9 g/mol | CONFORMS |
| Appearance | Pre-mixed aqueous solution | CONFORMS |
